학술논문

The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors
Document Type
Article
Source
In Cell Chemical Biology 17 February 2022 29(2):202-214
Subject
Language
ISSN
2451-9456